BRPI1010516A2 - Métodos de tratamento de edema relacionados à isquemia-reperfusão - Google Patents

Métodos de tratamento de edema relacionados à isquemia-reperfusão

Info

Publication number
BRPI1010516A2
BRPI1010516A2 BRPI1010516-6A BRPI1010516A BRPI1010516A2 BR PI1010516 A2 BRPI1010516 A2 BR PI1010516A2 BR PI1010516 A BRPI1010516 A BR PI1010516A BR PI1010516 A2 BRPI1010516 A2 BR PI1010516A2
Authority
BR
Brazil
Prior art keywords
reperfusion
ischemia
treatment methods
related edema
edema treatment
Prior art date
Application number
BRPI1010516-6A
Other languages
English (en)
Inventor
Thomas Michael Egan
Original Assignee
Univ North Carolina
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ North Carolina filed Critical Univ North Carolina
Publication of BRPI1010516A2 publication Critical patent/BRPI1010516A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/02—Preservation of living parts
    • A01N1/0205—Chemical aspects
    • A01N1/021—Preservation or perfusion media, liquids, solids or gases used in the preservation of cells, tissue, organs or bodily fluids
    • A01N1/0226—Physiologically active agents, i.e. substances affecting physiological processes of cells and tissue to be preserved, e.g. anti-oxidants or nutrients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
BRPI1010516-6A 2009-04-09 2010-04-09 Métodos de tratamento de edema relacionados à isquemia-reperfusão BRPI1010516A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US16808909P 2009-04-09 2009-04-09
PCT/US2010/030556 WO2010118334A1 (en) 2009-04-09 2010-04-09 Methods of treating edema related to ischemia-reperfusion

Publications (1)

Publication Number Publication Date
BRPI1010516A2 true BRPI1010516A2 (pt) 2015-08-25

Family

ID=42936599

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI1010516-6A BRPI1010516A2 (pt) 2009-04-09 2010-04-09 Métodos de tratamento de edema relacionados à isquemia-reperfusão

Country Status (14)

Country Link
US (1) US20120064044A1 (pt)
EP (1) EP2416651A4 (pt)
JP (1) JP2012523432A (pt)
KR (1) KR20120005025A (pt)
CN (1) CN102458113A (pt)
AU (1) AU2010233151A1 (pt)
BR (1) BRPI1010516A2 (pt)
CA (1) CA2757998A1 (pt)
EA (1) EA201101349A1 (pt)
IL (1) IL215604A0 (pt)
MX (1) MX2011010616A (pt)
SG (1) SG175133A1 (pt)
WO (1) WO2010118334A1 (pt)
ZA (1) ZA201107815B (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2009234156A1 (en) * 2008-04-09 2009-10-15 The University Of North Carolina At Chapel Hill Methods of regulating actin cytoskeletal rearrangement and intercellular gap formation
CA2828002A1 (en) * 2011-03-03 2012-09-07 Quark Pharmaceuticals, Inc. Compositions and methods for treating lung disease and injury
US10531655B2 (en) 2011-12-02 2020-01-14 The Regents Of The University Of California Reperfusion protection solution and uses thereof
JP7330893B2 (ja) 2017-03-10 2023-08-22 ザ ユニバーシティ オブ ノース カロライナ アット チャペル ヒル 短時間作用型ヘパリンベースの抗凝集剤化合物及び方法
US11865137B2 (en) 2017-11-03 2024-01-09 The University Of North Carolina At Chapel Hill Sulfated oligosaccharides having anti-inflammatory activity
US11458151B2 (en) 2018-02-12 2022-10-04 Inimmune Corporation Toll-like receptor ligands
JP2021528421A (ja) 2018-06-20 2021-10-21 ザ ユニバーシティ オブ ノース カロライナ アット チャペル ヒルＴｈｅ Ｕｎｉｖｅｒｓｉｔｙ Ｏｆ Ｎｏｒｔｈ Ｃａｒｏｌｉｎａ Ａｔ Ｃｈａｐｅｌ Ｈｉｌｌ 細胞保護の方法と組成物
WO2021097345A1 (en) * 2019-11-13 2021-05-20 The University Of North Carolina At Chapel Hill Heparan sulfate (hs) oligosaccharides effect in liver ischemia reperfusion injury

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH05139992A (ja) * 1991-11-13 1993-06-08 Ajinomoto Co Inc ヒトａｄｆを含有する臓器保護剤
US6113918A (en) * 1997-05-08 2000-09-05 Ribi Immunochem Research, Inc. Aminoalkyl glucosamine phosphate compounds and their use as adjuvants and immunoeffectors
US7960522B2 (en) * 2003-01-06 2011-06-14 Corixa Corporation Certain aminoalkyl glucosaminide phosphate compounds and their use
WO2004085396A1 (ja) * 2003-03-26 2004-10-07 Mitsubishi Pharma Corporation 虚血再灌流障害の予防または治療剤、臓器保存剤およびスクリーニング方法
US20060211752A1 (en) * 2004-03-16 2006-09-21 Kohn Leonard D Use of phenylmethimazoles, methimazole derivatives, and tautomeric cyclic thiones for the treatment of autoimmune/inflammatory diseases associated with toll-like receptor overexpression
US7928132B2 (en) * 2004-08-06 2011-04-19 Ohio University Methods for the amelioration of episodes of acute or chronic ulcerative colitis
EP2170366B1 (en) * 2007-08-03 2013-11-06 Opsona Therapeutics Limited Use of tlr-2 antagonists for treatment of reperfusion injury and tissue damage
AU2009234156A1 (en) * 2008-04-09 2009-10-15 The University Of North Carolina At Chapel Hill Methods of regulating actin cytoskeletal rearrangement and intercellular gap formation

Also Published As

Publication number Publication date
MX2011010616A (es) 2012-03-14
SG175133A1 (en) 2011-12-29
CN102458113A (zh) 2012-05-16
EP2416651A1 (en) 2012-02-15
CA2757998A1 (en) 2010-10-14
US20120064044A1 (en) 2012-03-15
ZA201107815B (en) 2013-04-24
AU2010233151A1 (en) 2011-11-17
KR20120005025A (ko) 2012-01-13
EA201101349A1 (ru) 2012-05-30
WO2010118334A1 (en) 2010-10-14
IL215604A0 (en) 2011-12-29
JP2012523432A (ja) 2012-10-04
EP2416651A4 (en) 2014-03-26

Similar Documents

Publication Publication Date Title
BRPI0910854A2 (pt) métodos de tratamento
BR112012005594A2 (pt) tratamento de câncer
BRPI0910259A2 (pt) métodos de tratamento de inflamação
BRPI0914841A2 (pt) aparelho de massagem
BR112012023753A2 (pt) tratamento de resíduos orgânicos
ATE526024T1 (de) Fluvoxamin vermeidende pirfenidontheraphy
DK2330887T3 (da) Behandlingsindretning
DK2173831T3 (da) Brøndbehandling
BRPI1010516A2 (pt) Métodos de tratamento de edema relacionados à isquemia-reperfusão
BR112013022820A2 (pt) método de tratamento
BRPI1007543A2 (pt) tratamento de psoríase
BR112012004071A2 (pt) tratamento de petróleo
BRPI1013903A2 (pt) tratamentos terapêuticos utilizando centaquina
DK2437839T3 (da) Lysbehandlingsindretning
BR112012010525A2 (pt) novos processos
IT1403226B1 (it) Trattamento impermeabilizzante
BRPI0922216A2 (pt) tratamento para glomerulonefrite
FI9141U1 (fi) Apuväline
ES1069855Y (es) Atrapamoscas
UA20620S (uk) Масажер
FI20080378A0 (fi) Parannettu hierontalaite
BR112012008961A2 (pt) tratamento de êmese
SE0801580L (sv) Massageredskap
TH93330B (th) รางระบายน้ำ
FI20090513A0 (fi) Tehokas prosessi

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 4A E 5A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2344 DE 08-12-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.